search
Back to results

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss

Primary Purpose

Obese, Overweight, Miscarriage

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Structured Weight Loss Program
Routine Weight Loss Counseling
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obese focused on measuring Miscarriage, Recurrent Pregnancy Loss, Obesity, Overweight, Diet

Eligibility Criteria

18 Years - 39 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Unexplained recurrent pregnancy loss (2 or more prior miscarriages)
  2. BMI >=25 kg/m2
  3. Prepared to take 3 months ¡®time out¡± from attempting to conceive
  4. Ability to attend a one hour initial, then 30 minute follow-up nutrition/monitoring session - once per week for one month, then every other week for 2 months, then once then once per month for 3 months.

Exclusion Criteria:

  1. Age >=40 years
  2. Diagnosis of Type 1 or Type 2 Diabetes as defined by a fasting glucose >=126, or 2 hour glucose >=200 by a 75 gram oral glucose challenge
  3. Presence of an endocrine condition such as hyperprolactinemia, Cushing¡-s syndrome or untreated thyroid disease (defined as a TSH outside of the laboratory determined normal range)
  4. Desire to continue attempts to conceive for the duration of the program
  5. History of bariatric surgery
  6. Use of over-the-counter or prescribed weight loss medications with the exception of metformin
  7. Enrollment in another clinical trial (excluding surveys)

Sites / Locations

  • Stanford University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Structured Weight Loss

Routine Weight Loss Counseling

Arm Description

Women randomized to this arm will meet with a registered dietician regularly for review of calorie recommendations and food diary. As well as regular clinic visits to measure patients weight.

Patients are counseled by a physicians about the impact of maternal weight on fertility and pregnancy outcomes.

Outcomes

Primary Outcome Measures

Term live birth rate

Secondary Outcome Measures

Weight loss - goal for weight loss defined as 5 percent of enrollment body weight lost
Changes in triglyceride levels
Changes in high density lipoprotein levels
Changes in alanine aminotransferase (ALT) levels
Changes in fasting insulin levels
Changes in postprandial insulin levels
Changes in fasting glucose levels
Changes in postprandial glucose levels
Changes in hemoglobin A1c levels

Full Information

First Posted
March 23, 2011
Last Updated
December 10, 2021
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT01325805
Brief Title
Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss
Official Title
Pregnancy Outcomes in Overweight and Obese Women With a History of Recurrent Pregnancy Loss Randomized to a Structured Weight Loss Program Versus Routine Weight-Loss Counseling: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Difficult to recruit, very poor compliance with interventions
Study Start Date
December 2010 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Overweight and obesity has been associated with a number of adverse pregnancy outcomes in women of reproductive age, including infertility and early pregnancy loss. Recent data suggests that overweight and obese patients are also at increased risk of recurrent pregnancy loss (RPL), a devastating condition that affects 1% of the fertile population. The investigators propose a prospective, randomized controlled trial in which overweight and obese patients with unexplained recurrent pregnancy loss are enrolled in a structured, 6 month, weight loss program or provided routine counseling regarding the importance of weight loss. Pregnancy outcomes will then be followed to assess miscarriage rates. Metabolic outcomes, such as lipid and glucose profiles, will also be evaluated.
Detailed Description
The purpose of this study is to investigate the impact of a structured weight loss program versus traditional weight-loss counseling on pregnancy outcomes in women with recurrent pregnancy loss. The study protocol is as follows: Patients will be notified of study via flyer inserted into patient chart at initial clinic visit, physician referral or Stanford website. Patients expressing interest will have their charts reviewed to confirm that they meet all enrollment criteria. Potential subjects will then be contacted via phone and verbal consent to participate obtained. The participant will then have an office visit for consent signing and randomization. A formal weight will be obtained, the Beck Depression Inventory will be administered by Penny Donnelly, a self-administered questionnaire will be completed, and a basic laboratory evaluation, including a fasting lipid panel, alanine aminotransferase (ALT), fasting glucose and insulin levels, 2-hour glucose tolerance test, hemoglobin A1c and CRP will be preformed. The patients will then be randomized to traditional weight loss counseling (control group) or to the structured weight loss program (study group). Patients will be instructed to discontinue attempts at conception. Those patients randomized to the control group will receive the ACOG Patient Education pamphlets on obesity. Those patients randomized to the study group will have a formal evaluation and counseling by Dr. Sun Kim, a medical endocrinologist specializing in weight management. They will then be enrolled in a structured weight loss program. For all patients, a 3-month follow-up office visit will be scheduled. At this visit, a formal weight will be obtained, the Beck Depression Inventory will be re-administered by Penny Donnelly, a self-administered questionnaire will be completed, and a follow-up laboratory evaluation, including a fasting lipid panel, alanine aminotransferase (ALT), fasting glucose and insulin levels, 2-hour glucose tolerance test, hemoglobin A1c and CRP will be preformed. Patients will be informed that they may now being attempts to conceive. Patients randomized to the study group will continue in the structured weight loss program for 6 months. Six months after enrollment, all patients will have a telephone interview in which a close-out questionnaire will be administered and a final, self-reported weight will be obtained. Primary and secondary outcomes will be followed for 2.5 years after date of enrollment for all patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obese, Overweight, Miscarriage, Recurrent Pregnancy Loss
Keywords
Miscarriage, Recurrent Pregnancy Loss, Obesity, Overweight, Diet

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Structured Weight Loss
Arm Type
Experimental
Arm Description
Women randomized to this arm will meet with a registered dietician regularly for review of calorie recommendations and food diary. As well as regular clinic visits to measure patients weight.
Arm Title
Routine Weight Loss Counseling
Arm Type
Active Comparator
Arm Description
Patients are counseled by a physicians about the impact of maternal weight on fertility and pregnancy outcomes.
Intervention Type
Behavioral
Intervention Name(s)
Structured Weight Loss Program
Intervention Description
Those patients randomized to the structured weight loss group will have a formal evaluation and counseling a medical endocrinologist specializing in weight management. The structured weight loss program will consist of meeting with a dietician who will guide them on following a hypocaloric diet with a calorie deficit of 750kcal/day. The weight loss goal will be to lose 1-1.5 pounds/week. The participants will receive teaching utilizing the American Diabetes Association Exchange Lists and will receive sample meal plans. In addition, participants will be seen by the dietitian once a week for a month, then every 2 weeks for 2 months, then once per month for 3 months. Patients randomized to the study group will continue in the structured weight loss program for 6 months.
Intervention Type
Behavioral
Intervention Name(s)
Routine Weight Loss Counseling
Intervention Description
Participants randomized to the routine weight loss counseling group will receive the ACOG Patient Education pamphlets on obesity.
Primary Outcome Measure Information:
Title
Term live birth rate
Time Frame
2.5 years
Secondary Outcome Measure Information:
Title
Weight loss - goal for weight loss defined as 5 percent of enrollment body weight lost
Time Frame
6 months
Title
Changes in triglyceride levels
Time Frame
3 months
Title
Changes in high density lipoprotein levels
Time Frame
3 months
Title
Changes in alanine aminotransferase (ALT) levels
Time Frame
3 months
Title
Changes in fasting insulin levels
Time Frame
3 months
Title
Changes in postprandial insulin levels
Time Frame
3 months
Title
Changes in fasting glucose levels
Time Frame
3 months
Title
Changes in postprandial glucose levels
Time Frame
3 months
Title
Changes in hemoglobin A1c levels
Time Frame
3 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Unexplained recurrent pregnancy loss (2 or more prior miscarriages) BMI >=25 kg/m2 Prepared to take 3 months ¡®time out¡± from attempting to conceive Ability to attend a one hour initial, then 30 minute follow-up nutrition/monitoring session - once per week for one month, then every other week for 2 months, then once then once per month for 3 months. Exclusion Criteria: Age >=40 years Diagnosis of Type 1 or Type 2 Diabetes as defined by a fasting glucose >=126, or 2 hour glucose >=200 by a 75 gram oral glucose challenge Presence of an endocrine condition such as hyperprolactinemia, Cushing¡-s syndrome or untreated thyroid disease (defined as a TSH outside of the laboratory determined normal range) Desire to continue attempts to conceive for the duration of the program History of bariatric surgery Use of over-the-counter or prescribed weight loss medications with the exception of metformin Enrollment in another clinical trial (excluding surveys)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruth Bunker Lathi
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
19007647
Citation
Practice Committee of tAmerican Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008 Nov;90(5 Suppl):S60. doi: 10.1016/j.fertnstert.2008.08.065.
Results Reference
background
PubMed Identifier
12398226
Citation
Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update. 2002 Sep-Oct;8(5):463-81. doi: 10.1093/humupd/8.5.463.
Results Reference
background
PubMed Identifier
15475226
Citation
James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004 Jul-Aug;22(4):276-80. doi: 10.1016/j.clindermatol.2004.01.010.
Results Reference
background
PubMed Identifier
20014418
Citation
Shirazian T, Raghavan S. Obesity and pregnancy: implications and management strategies for providers. Mt Sinai J Med. 2009 Dec;76(6):539-45. doi: 10.1002/msj.20148.
Results Reference
background
PubMed Identifier
8030695
Citation
Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994 Jul;171(1):171-7. doi: 10.1016/0002-9378(94)90465-0.
Results Reference
background
PubMed Identifier
9822077
Citation
Jensen MD. Medical management of obesity. Semin Gastrointest Dis. 1998 Oct;9(4):156-62.
Results Reference
background
PubMed Identifier
10873131
Citation
Bolumar F, Olsen J, Rebagliato M, Saez-Lloret I, Bisanti L. Body mass index and delayed conception: a European Multicenter Study on Infertility and Subfecundity. Am J Epidemiol. 2000 Jun 1;151(11):1072-9. doi: 10.1093/oxfordjournals.aje.a010150.
Results Reference
background
PubMed Identifier
18077317
Citation
van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, Oosterhuis GJ, Bossuyt PM, van der Veen F, Mol BW. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008 Feb;23(2):324-8. doi: 10.1093/humrep/dem371. Epub 2007 Dec 11.
Results Reference
background
PubMed Identifier
18068166
Citation
Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008 Sep;90(3):714-26. doi: 10.1016/j.fertnstert.2007.07.1290. Epub 2008 Feb 6.
Results Reference
background
PubMed Identifier
15142995
Citation
Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004 Jul;19(7):1644-6. doi: 10.1093/humrep/deh277. Epub 2004 May 13.
Results Reference
background
PubMed Identifier
12055331
Citation
Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res. 2002 Jun;10(6):551-4. doi: 10.1038/oby.2002.74.
Results Reference
background
PubMed Identifier
19439294
Citation
Metwally M, Saravelos SH, Ledger WL, Li TC. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril. 2010 Jun;94(1):290-5. doi: 10.1016/j.fertnstert.2009.03.021. Epub 2009 May 12.
Results Reference
background
PubMed Identifier
9688382
Citation
Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998 Jun;13(6):1502-5. doi: 10.1093/humrep/13.6.1502.
Results Reference
background
Links:
URL
https://fertility.stanfordchildrens.org
Description
Stanford Fertility & Reproductive Medicine Center

Learn more about this trial

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss

We'll reach out to this number within 24 hrs